Vera Therapeutics CEO Fordyce Marshall disposes of USD 684,500 in common shares
VERA•CEO shares and option activity
Vera Therapeutics President and CEO Marshall Fordyce exercised stock options for 18,500 Class A shares at $2.9 and sold 18,500 Class A shares at $37 in the same filing.
- Direct Class A holdings fell to 235,244 shares.
- Stock options beneficially owned rose to 488,801 following the transaction.



